Patents-Review.com
ClassID:

170653 ⎘

G01N2333/928 - CPC Classification

Classification description:

Assays involving biological materials from specific organisms or of a specific nature; Enzymes; Proenzymes; Hydrolases (3) acting on glycosyl compounds (3.2) acting on alpha -1, 4-glucosidic bonds, e.g. hyaluronidase, invertase, amylase acting on alpha -1, 4-glucosidic bonds, e.g. hyaluronidase, invertase, amylase

Sub-classes:
Recent Application in this class:
#1
20260009791
2026-01-08

ANALYTICAL METHODS, DEVICES AND KITS FOR USE THEREIN

 #2
20250306036
2025-10-02

BIOMARKER COMPOSITION FOR EARLY DIAGNOSIS OF KIDNEY DISEASES, AND METHOD FOR PROVIDING INFORMATION REQUIRED FOR EARLY DIAGNOSIS OF KIDNEY DISEASES BY USING SAME

 #3
20250197836
2025-06-19

PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF

 #4
20250197835
2025-06-19

PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF

 #5
20250197834
2025-06-19

PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF

 #6
20250197833
2025-06-19

PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF

 #7
20250197832
2025-06-19

PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF

 #8
20250172571
2025-05-29

Biosignatures for Fatigue Syndromes

 #9
20250154488
2025-05-15

PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF

 #10
20250051747
2025-02-13

PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF

 #11
20240417807
2024-12-19

DETECTING NEOPLASM

 #12
20240318158
2024-09-26

PH20 polypeptide variants, formulations and uses thereof

 #13
20240209337
2024-06-27

PH20 polypeptide variants, formulations and uses thereof

 #14
20240069025
2024-02-29

METHOD FOR SIZE BASED EVALUATION OF PANCREATIC PROTEIN MIXTURE

 #15
20240026328
2024-01-25

PH20 polypeptide variants, formulations and uses thereof

 #16
20240026327
2024-01-25

PH20 polypeptide variants with a modification at position 309 of the PH20 polypeptide and a method of making thereof

 #17
20240011008
2024-01-11

PH20 polypeptide variants, formulations and uses thereof

 #18
20240002826
2024-01-04

PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF

 #19
20240002825
2024-01-04

PH20 polypeptide variants, formulations and uses thereof

 #20
20230357739
2023-11-09

PH20 polypeptide variants, formulations and uses thereof

 #21
20230341396
2023-10-26

METHODS AND RELATED ASPECTS FOR PATHOGEN DETECTION

 #22
20230295593
2023-09-21

PH20 polypeptide variants, formulations and uses thereof

 #23
20230295592
2023-09-21

PH20 polypeptide variants, formulations and uses thereof

 #24
20230287381
2023-09-14

PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF

 #25
20230272482
2023-08-31

Detecting neoplasm

 #26
20230250409
2023-08-10

PH20 polypeptide variants, formulations and uses thereof

 #27
20230212547
2023-07-06

PH20 polypeptide variants, formulations and uses thereof

 #28
20230151346
2023-05-18

PH20 polypeptide variants, formulations and uses thereof

 #29
20230027132
2023-01-26

Binding proteins for the enzyme acid alpha glucosidase (GAA) and uses thereof

 #30
20220390422
2022-12-08

DETECTION OF TESTING ERRORS IN LATERAL FLOW ASSAYS

 #31
20220307064
2022-09-29

COMPOSITIONS AND METHODS FOR PREDICTING AND PROMOTING WEIGHT LOSS IN PATIENTS WITH LOW AMY1 COPY NUMBERS

 #32
20220020451
2022-01-20

Method for evaluating metabolizable energy in goose diet by using a simulative digestion gross energy technique

 #33
20210333287
2021-10-28

Method for acquiring information of target polypeptide and reagent kit

 #34
20210284985
2021-09-16

PH20 polypeptide variants, formulations and uses thereof

 #35
20210277376
2021-09-09

PH20 polypeptide variants, formulations and uses thereof

 #36
20200318091
2020-10-08

PH20 polypeptide variants, formulations and uses thereof

 #37
20200255814
2020-08-13

PH20 polypeptide variants, formulations and uses thereof

 #38
20200131587
2020-04-30

Detecting neoplasm

 #39
20200049700
2020-02-13

NANOPARTICLE-ENHANCED ENZYMATIC IMMUNE BIOSENSOR ASSAY FOR ANTIGEN DETECTION

 #40
20180363024
2018-12-20

Methods and devices for diagnosis of particles in biological fluids

 #41
20180321217
2018-11-08

Cyst fluid viscosity as a marker for malignancy

 #42
20180237821
2018-08-23

APPARATUS AND METHOD TO READ BIOLOGICAL INDICATOR

 #43
20180105886
2018-04-19

Detecting neoplasm

 #44
20170275668
2017-09-28

Method of measuring alpha amylase

 #45
20170198361
2017-07-13

Detecting neoplasm

 #46
20160362670
2016-12-15

PH20 polypeptide variants, formulations and uses thereof

 #47
20160305946
2016-10-20

Detecting neoplasm

 #48
20160282343
2016-09-29

QUANTITATIVE LATERAL FLOW ASSAY STRIPS FOR QUANTITATIVE ANALYSIS OF AN ANALYTE, KITS CONTAINING SUCH STRIPS AND METHODS OF MANUFACTURE AND USE OF SAME

 #49
20160130632
2016-05-12

Methods and devices for diagnosis of particles in biological fluids

 #50
20160061836
2016-03-03

Methods relating to testing for lysosomal storage disorders

 #51
20160010071
2016-01-14

ENDOLYSIN OBPGPLYS

 #52
20150269311
2015-09-24

Diagnosis and risk stratification of bladder cancer

 #53
20150147309
2015-05-28

ALLOSTERIC CHAPERONES AND USES THEREOF

 #54
20150050664
2015-02-19

Assay for measuring enzymatic modification of a substrate by a glycoprotein having enzymatic activity

 #55
20140178330
2014-06-26

PH20 polypeptide variants, formulations and uses thereof

 #56
20130302275
2013-11-14

PH20 polypeptide variants, formulations and uses thereof

 #57
20120329070
2012-12-27

Biomarker panels for assessing radiation injury and exposure

 #58
20120189608
2012-07-26

Endolysin OBPgpLYS

 #59
20110287409
2011-11-24

DIAGNOSTIC DEVICE AND METHOD

 #60
20110183328
2011-07-28

Detecting neoplasm

 #61
20110136151
2011-06-09

ASSAYS FOR DIAGNOSING AND EVALUATING TREATMENT OPTIONS FOR POMPE DISEASE

 #62
20100330684
2010-12-30

DIAGNOSTIC DEVICE AND METHOD

 #63
20100240082
2010-09-23

METHODS FOR DETECTING AND MEASURING POLYSACCHARIDE-HYDROLYZING ENZYMES

 #64
20100151439
2010-06-17

Method of conducting a droplet based enzymatic assay

 #65
18778554
2025-04-01

PH20 polypeptide variants, formulations and uses thereof